Gisela Schwab, President, Prod Development & Med Aff & CMO at EXELIXIS, INC. (EXEL), sold 150,000 shares at $19.60 ($2.9M) on 2020-03-04, disclosed to the SEC on 2020-03-06.
Seasonal sale ($2.9M) by President, Prod Development & Med Aff & CMO — this insider has traded EXEL in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.20 | 50,000 | $960K | 32.9% |
| 2 | $19.60 | 50,000 | $980K | 33.6% |
| 3 | $19.60 | 50,000 | $980K | 33.6% |
| Total | $19.47 avg | 150,000 | $2.9M | 100% |
| Filing → |
| EXEL | SELL | 2021-04-02 | $1.1M | — | Filing → |
| EXEL | SELL | 2021-02-19 | $2.2M | — | Filing → |
| EXEL | SELL | 2020-06-05 | $2.3M | — | Filing → |